Pulmonary delivery of pyrazinamide-loaded large porous particles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 94, Issue , 2015, Pages 241-250

  Pham, Dinh Duy ^a,b,c   Grégoire, Nicolas ^d   Couet, William ^d   Gueutin, Claire ^a   Fattal, Elias ^a   Tsapis, Nicolas ^a  

^a UNIV PARIS SUD   (France)

^b UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^c TON DUC THANG UNIVERSITY   (Viet Nam)

^d UNIVERSITÉ DE POITIERS   (France)

Author keywords

Aerodynamic properties; Lung delivery; Pharmacokinetics; Pyrazinamide; Tuberculosis

Indexed keywords

DRUG CARRIER; LARGE POROUS PARTICLE; PYRAZINAMIDE; UNCLASSIFIED DRUG; POWDER; TUBERCULOSTATIC AGENT;

AERATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; AREA UNDER THE MOMENT CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG PENETRATION; EPITHELIAL LINING FLUID; GEOMETRY; IN VIVO STUDY; LUNG BARRIER; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN ABSORPTION TIME; MEAN RESIDENCE TIME; NONHUMAN; PARTICLE SIZE; PERMEABILITY BARRIER; PLASMA CONCENTRATION-TIME CURVE; RAT; SPRAY DRYING; SYSTEMIC CIRCULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; BIOAVAILABILITY; CHEMISTRY; DRUG FORMULATION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG; METABOLISM; POROSITY; POWDER; SCANNING ELECTRON MICROSCOPY; SPRAGUE DAWLEY RAT; SURFACE PROPERTY;

ADMINISTRATION, INHALATION; ANIMALS; ANTITUBERCULAR AGENTS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG COMPOUNDING; INJECTIONS, INTRAVENOUS; LUNG; MALE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POROSITY; POWDERS; PYRAZINAMIDE; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES;

EID: 84931267925     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.05.021     Document Type: Article

References (49)

1. R.G. Ducati, A. Ruffino-Netto, L.A. Basso, and D.S. Santos The resumption of consumption: a review on tuberculosis Memór. Inst. Oswaldo Cruz 101 2006 697 714
2. J.D. Grodon Antituberculous therapy L.I. Lutwick, Tuberculosis. A clinical handbook 1995 Chapman & Hall New York 295 316
3. E. Mutschler, and H. Derendorf Drug Actions: Basic Principles and Therapeutic Aspects 1995 Medpharm; CRC Press Stuttgart; Boca Raton (FL); Ann Arbor; London [etc.]
4. WHO, Global Tuberculosis Report 2013, Geneva, Switzerland, 2013.
5. P. Muttil, C. Wang, and A. Hickey Inhaled drug delivery for tuberculosis therapy Pharm. Res. 26 2009 2401 2416
6. L.V. Sacks, S. Pendle, D. Orlovic, M. Andre, M. Popara, G. Moore, L. Thonell, and S. Hurwitz Adjunctive salvage therapy with inhaled aminoglycosides for patients with persistent smear-positive pulmonary tuberculosis Clin. Infect. Dis. 32 2001 44 49
7. D.A. Mitchison The action of antituberculosis drugs in short-course chemotherapy Tubercle 66 1985 219 225
8. Y. Zhang, and D. Mitchison The curious characteristics of pyrazinamide: a review Int. J. Tuberc. Lung Dis. 7 2003 6 21
9. L. Heifets, and P. Lindholm-Levy Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations Am. J. Respir. Crit. Care Med. 145 1992 1223 1225
10. N. Tsapis, D. Bennett, K. O'Driscoll, K. Shea, M.M. Lipp, K. Fu, R.W. Clarke, D. Deaver, D. Yamins, J. Wright, C.A. Peloquin, D.A. Weitz, and D.A. Edwards Direct lung delivery of para-aminosalicylic acid by aerosol particles Tuberculosis (Edinb) 83 2003 379 385
11. G.C. Wood, and J.M. Swanson Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia Drugs 67 2007 903 914
12. R. Pandey, A. Zahoor, S. Sharma, and G.K. Khuller Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis Tuberculosis 83 2003 373 378
13. G. Chimote, and R. Banerjee In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis J. Biomed. Mater. Res. B: Appl. Biomater. 94 2010 1 10
14. P. Deol, G.K. Khuller, and K. Joshi Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice Antimicrob. Agents Chemother. 41 1997 1211 1214
15. P. Muttil, J. Kaur, K. Kumar, A.B. Yadav, R. Sharma, and A. Misra Inhalable microparticles containing large payload of anti-tuberculosis drugs Eur. J. Pharm. Sci. 32 2007 140 150
16. S. Suarez, P. O'Hara, M. Kazantseva, C.E. Newcomer, R. Hopfer, D.N. McMurray, and A.J. Hickey Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model Pharm. Res. 18 2001 1315 1319
17. L. Garcia-Contreras, J. Fiegel, M.J. Telko, K. Elbert, A. Hawi, M. Thomas, J. VerBerkmoes, W.A. Germishuizen, P.B. Fourie, A.J. Hickey, and D. Edwards Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model Antimicrob. Agents Chemother. 51 2007 2830 2836
18. D. Pham, E. Fattal, and N. Tsapis Pulmonary drug delivery systems for tuberculosis treatment Int. J. Pharm. 478 2014 517 529
19. D.A. Edwards, and C. Dunbar Bioengineering of therapeutic aerosols Annu. Rev. Biomed. Eng. 4 2002 93 107
20. D.A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. Ben-Jebria, M.L. Eskew, J. Mintzes, D. Deaver, N. Lotan, and R. Langer Large porous particles for pulmonary drug delivery Science 276 1997 1868 1871
21. C.A. Dunbar, A.J. Hickey, and P. Holzner Dispersion and characterization of pharmaceutical dry powder aerosols Kona 16 1998 7 45
22. D.A. Edwards Delivery of biological agents by aerosols AIChE J. 48 2002 2 6
23. D.D. Pham, E. Fattal, N. Ghermani, N. Guiblin, and N. Tsapis Formulation of pyrazinamide-loaded large porous particles for the pulmonary route: avoiding crystal growth using excipients Int. J. Pharm. 454 2013 668 677
24. Preparations for inhalation: aerodynamic assessment of fine particles - fine particle dose and particle size distribution, in: European Pharmacopoeia (Ph. Eur.), Addendum, Strasbourg, 2013, pp. 309-320.
25. J.L. Mauderly Bronchopulmonary lavage of small laboratory animals Lab. Anim. Sci. 27 1977 255 261
26. J.E. Conte Jr., E. Lin, and E. Zurlinden High-performance liquid chromatographic determination of pyrazinamide in human plasma, bronchoalveolar lavage fluid, and alveolar cells J. Chromatogr. Sci. 38 2000 33 37
27. J.B. Bulitta, A. Bingolbali, B.S. Shin, and C.B. Landersdorfer Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT AAPS J. 13 2011 201 211
28. A.V. Gontijo, J. Brillault, N. Gregoire, I. Lamarche, P. Gobin, W. Couet, and S. Marchand Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin Antimicrob. Agents Chemother. 58 2014 3942 3949
29. S.L. Beal Ways to fit a PK model with some data below the quantification limit J. Pharmacokinet. Pharmacodyn. 28 2001 481 504
30. M. Dolovich Measurement of particle size characteristics of metered dose inhaler (MDI) aerosols J. Aerosol Med. 4 1991 251 263
31. C. Papastefanou Aerosol sampling and measurement techniques Radioactive Aerosols 2008 Elsevier Greece 113 159
32. Aliasgar J. Kundawala, Vishnu A. Patel, Harsha V. Patel, and D. Choudhary Influence of formulation components on aerosolization properties of isoniazid loaded chitosan microspheres Int. J. Pharm. Sci. Drug Res. 3 2011 297 302
33. C. Bosquillon, C. Lombry, V. Préat, and R. Vanbever Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance J. Control. Release 70 2001 329 339
34. C. Bosquillon, P.G. Rouxhet, F. Ahimou, D. Simon, C. Culot, V. Préat, and R. Vanbever Aerosolization properties, surface composition and physical state of spray-dried protein powders J. Control. Release 99 2004 357 367
35. C. Bosquillon, V. Préat, and R. Vanbever Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats J. Control. Release 96 2004 233 244
36. G. Pilcer, F. Vanderbist, and K. Amighi Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations Int. J. Pharm. 358 2008 75 81
37. E.L. Cussler Diffusion: Mass Transfer in Fluid Systems second ed. 1997 Cambridge University Press
38. B. Adhikari, T. Howes, A. Shrestha, and B.R. Bhandari Effect of surface tension and viscosity on the surface stickiness of carbohydrate and protein solutions J. Food Eng. 79 2007 1136 1143
39. M. Cano-Chauca, P.C. Stringheta, A.M. Ramos, and J. Cal-Vidal Effect of the carriers on the microstructure of mango powder obtained by spray drying and its functional characterization Innov. Food Sci. Emerg. Technol. 6 2005 420 428
40. O.R. Roustapour, M. Hosseinalipour, and B. Ghobadian An experimental investigation of lime juice drying in a pilot plant spray dryer Drying Technol. 24 2006 181 188
41. N. Tsapis, D. Bennett, B. Jackson, D.A. Weitz, and D.A. Edwards Trojan particles: large porous carriers of nanoparticles for drug delivery Proc. Natl. Acad. Sci. USA 99 2002 12001 12005
42. G. Marty, and N. Tsapis Monitoring the buckling threshold of drying colloidal droplets using water-ethanol mixtures Eur. Phys. J. E 27 2008 213 219
43. A. Minne, H. Boireau, M.J. Horta, and R. Vanbever Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients Eur. J. Pharm. Biopharm. 70 2008 839 844
44. C. Gómez Gaete, N. Tsapis, L. Silva, C. Bourgaux, and E. Fattal Morphology, structure and supramolecular organization of hybrid 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine-hyaluronic acid microparticles prepared by spray drying Eur. J. Pharm. Sci. 34 2008 12 21
45. R. Wolfenden, L. Andersson, P.M. Cullis, and C.C.B. Southgate Affinities of amino acid side chains for solvent water Biochemistry 20 1981 849 855
46. J. Gliński, G. Chavepeyer, and J.-K. Platten Surface properties of aqueous solutions of l-leucine Biophys. Chem. 84 2000 99 103
47. E. Kipnis Using urea as an endogenous marker of bronchoalveolar lavage dilution Crit. Care Med. 33 2005 2153 Author reply 2153-2154
48. S. Kiem, and J.J. Schentag Interpretation of antibiotic concentration ratios measured in epithelial lining fluid Antimicrob. Agents Chemother. 52 2008 24 36
49. C. Raynaud, M.A. Laneelle, R.H. Senaratne, P. Draper, G. Laneelle, and M. Daffe Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity Microbiology (Reading, England) 145 Pt 6 1999 1359 1367